Allen Bond

Global Tuberculosis Testing Market: Trend Analysis and Forecast to 2022

Press Release   •   Feb 22, 2017 17:51 IST

Tuberculosis is a highly infectious bacterial infection, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. Tuberculosis (TB) can be caught by breathing in air that an infected person has contaminated through: Breathing, coughing. Furthermore, the disease is ranked second leading cause of death, after human immunodeficiency virus (HIV). Individual majorly suffer from two predominant forms of TB: Active tuberculosis and Latent tuberculosis. The global tuberculosis testing market comprises diagnostic tests, equipment’s and testing procedures that contribute assistance in diagnostic of tuberculosis infection.

The global tuberculosis market is expected to grow at CAGR between 4.3% – 4.8% during the forecast period of 2016-2022 and reach USD XX billion by 2022. High numbers of increasing TB cases i.e. from 8.6 million in 2012 to 9 million in 2013, coupled with high prevalence and incidences of TB are the major factors responsible for high growth of tuberculosis testing market. In addition, availability of new improved tests, increasing awareness level, developing infrastructure and increased involvement of some of the world’s leading organizations such as WHO (World Health Organization) and FIND (Foundation for Innovative New Diagnostics) contributing to the global growth of this market. On the other hand, High cost associated with testing procedures, lack of specificity and requirement of specialized equipment’s are the prime challenges of this market that are likely to limit the global growth over the forecast period. Rising prevalence of TB, numerous tuberculosis awareness and control program launched by the government organizations and great market potential due to developing economies expected to bring new growth opportunities in near future.

Segments Covered:

The global tuberculosis testing market is segmented on the basis of tests, end users and regions. Market segmentation based on type of test includes Smear Microscope, Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing, Radiography, Drug Susceptibility Testing, and others. Hospitals and laboratories are the major end users of this market; however, it includes some of the other end users.

Geographic Coverage and Analysis:

The global market for tuberculosis has been segmented into for major regional markets- North America, Europe, Asia Pacific, and Rest of the World (RoW). As of 2013, Asia pacific registered largest share of overall tuberculosis testing market trailed by North America. Asia pacific is also the largest market for TB testing in terms of revenue and accounted for more than 36.0% of the global market followed by North America. The markets in Asia is primarily driven by the emerging economies such as India and china, presence of vast patient pool which is increasing at a rapid pace due to increasing rates of disease. North America is the second largest revenue generating region and forecasted to grow at rapid rate over the forecasted period.

Companies Profiled:

The companies covered in the report include

  • Abbott Laboratories
  • Akonni Biosystems, Inc
  • Alere, Inc
  • Becton
  • Dickinson and Company
  • bioMérieux SA
  • Cepheid
  • Epistem Holdings Plc
  • F. Hoffmann-La Roche Ltd

Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you’